Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001079973-20-000083
Filing Date
2020-02-05
Accepted
2020-02-05 16:43:58
Documents
12

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A opgen_s3a1.htm S-3/A 2544513
2 EXHIBIT 23.1 ex23x1.htm EX-23.1 2340
3 EXHIBIT 23.2 ex23x2.htm EX-23.2 2797
5 GRAPHIC opgen_logov1.jpg GRAPHIC 5381
6 GRAPHIC image_017.jpg GRAPHIC 30068
7 GRAPHIC image_018.jpg GRAPHIC 11593
8 GRAPHIC image_019.jpg GRAPHIC 17418
9 GRAPHIC image_020.jpg GRAPHIC 4571
10 GRAPHIC image_021.jpg GRAPHIC 6493
11 GRAPHIC ballard2019.jpg GRAPHIC 3584
12 GRAPHIC address.jpg GRAPHIC 5865
13 filename13.htm CORRESP 11647
  Complete submission text file 0001079973-20-000083.txt   2680482
Mailing Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878
Business Address 708 QUINCE ORCHARD ROAD SUITE 205 GAITHERSBURG MD 20878 240-813-1260
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

EIN.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-236106 | Film No.: 20579366
SIC: 8071 Services-Medical Laboratories